Status:
COMPLETED
Rivastigmine Capsules in Patients With Probable Vascular Dementia
Lead Sponsor:
Novartis
Conditions:
Vascular Dementia
Eligibility:
All Genders
50-85 years
Phase:
PHASE3
Brief Summary
The goal of this research study is to evaluate, in the open-label extension phase, the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 8...
Eligibility Criteria
Inclusion
- Patients who complete the double-blind treatment phase or those who have dropped out early in the study, but have returned for all the remaining scheduled efficacy assessments (retrieved drop-out patients) without significant protocol violations are eligible to participate.
Exclusion
- Retrieved drop-out patients, who have been treated with other cholinergic drugs during the past 4 weeks
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
521 Patients enrolled
Trial Details
Trial ID
NCT00130338
Start Date
February 1 2002
End Date
May 1 2006
Last Update
March 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.